Fundraising Fox
🦊/People
Sign in

Dirk Reyn

Investor

Managing Partner at Bioqube Ventures · Health Advisor at NPM Capital N.V.

Antwerp, Belgium

Writes $100K – $5M checks · typically $1.5M

Find your path to Dirk

267 people in our graph share verified history with Dirk — schools, employers, funds. One of them is your warm intro.

Hal PazunlockedDirk: together at Johnson & Johnson (2000–2001)
×2Dirk: together at Johnson & Johnson
Dirk: together at flanders.bio
×6Dirk: together at University of Antwerp

About

Dirk Reyn is Advisor and Managing Partner of Bioqube Factory Fund I with over 35 years of leadership in pharma and biotech. He began at Eli Lilly and Janssen-Cilag (J&J), co-founded and led Movetis NV to IPO and acquisition by Shire, founded Progress Pharma, and chaired Flanders.bio.

Contact· published on Dirk's own website

Invests in

Biotech

Experience

  1. NPM CapitalHealth Advisorcurrent2024 — presentAmsterdam Area
  2. Bioqube VenturesManaging Partnercurrent2016 — presentBrussel/Mechelen
  3. Egle TherapeuticsBoard Membercurrent2021 — present
  4. Progress PharmaChairmancurrent2013 — presentBelgium
  5. Enhanced GenomicsBoard Member2024 — 2025Cambridge, England, United Kingdom
  6. FlandersBioMedviaBoard Member2025Ghent, Flemish Region, Belgium
  7. flanders.bioPresident - Voorzitter van de Raad van Bestuur2018 — 2025
  8. Across HealthChairman of Board2018 — 2020Gent Area, Belgium
  9. SpectricityCo-founder and Board member2018 — 2020Leuven
  10. Rotary InternationalPast President Rotary Turnhout2017 — 2018Turnhout
  11. eTheRNA ImmunotherapiesFounding CEO2016 — 2017Niel, Belgium
  12. ZembroBoardmember2015 — 2016Gent
  13. TiGenixBoardmember2011 — 2016Leuven
  14. BbyBShareholder and executive coach2011 — 2016Brugge - Antwerpen - London - Tokyo
  15. Horizon Pharmaventures BVBADirector2011 — 2014Vosselaar, Belgium
  16. Shire PharmaceuticalsVP New Business Opportunities ISP region2012 — 2013Turnhout
  17. Shire PharmaceuticalsResolor Product General Manager2010 — 2012Turnhout
  18. Shire-MovetisManaging Director at Shire-Movetis NV2010 — 2013Turnhout
  19. Movetis NV.CEO and founder2006 — 2010Turnhout
  20. J&JVP New Business Development EMEA2003 — 2006
  21. Janssen PharmaceuticaVP Customer Relationship management2001 — 2003Beerse
  22. Janssen PharmaceuticaVice President marketing1992 — 2001
  23. Johnson & JohnsonPrepulsid Team Leader1999 — 2001
  24. Eli LillySales Manager1984 — 1992

Skills & more

Board AdministrationBoard LevelBoard GovernanceBiotechnology75Lifesciences36Healthcare21Change Management20Coaching5Start-ups49Business Planning30R&D16Business Strategy72
+10 moreProject ManagementClinical DevelopmentMarketing StrategyNew Business DevelopmentClinical ResearchProduct ManagementClinical TrialsSales ManagementStrategic PlanningPharmaceutical Industry

Languages Dutch · English · French · German

From Dirk's professional profile.

Colleagues at Bioqube Ventures

Alexander Demoulin
Associate at Bioqube Ventures
Clement Salque
Associate at Bioqube Ventures
Debora Dumont
Managing Partner at Bioqube Ventures
Geert Tackaert
Finance Director at Bioqube Ventures
Jacques Mizrahi
Venture Partner at Bioqube Ventures
Janine Schuurman
Senior Advisor at Bioqube Ventures
Jon Edwards
Managing Partner at Bioqube Ventures
Joris De Maeyer
Executive in Residence at Bioqube Ventures

Network5

Alexander Demoulin
Associate at Bioqube Ventures
Clement Salque
Associate at Bioqube Ventures
Debora Dumont
Managing Partner at Bioqube Ventures
Jacques Mizrahi
Venture Partner at Bioqube Ventures
Joris De Maeyer
Executive in Residence at Bioqube Ventures

Investors connected to Dirk in public investor directories — a warm-intro map.

Frequently asked questions

Who is Dirk Reyn?
Dirk Reyn is Advisor and Managing Partner of Bioqube Factory Fund I with over 35 years of leadership in pharma and biotech. He began at Eli Lilly and Janssen-Cilag (J&J), co-founded and led Movetis NV to IPO and acquisition by Shire, founded Progress Pharma, and chaired Flanders.bio.
Where does Dirk Reyn work?
Dirk Reyn is Managing Partner at Bioqube Ventures.
What does Dirk Reyn invest in?
Dirk Reyn invests in Biotech.
What check size does Dirk Reyn write?
Dirk Reyn typically writes checks of $100K – $5M.
Where did Dirk Reyn go to school?
Dirk Reyn studied at Hogeschool Antwerpen (MBA, Master of Business Adminstration); University of Antwerp (master in pharmacy).

Founder mafias

Bioqube Ventures mafia2

Also came through, then founded or led a company.

Sandy ZweifachSenior AdvisorFounded Imidomics

Same school

Shared employers